| Serum Electrolyte Dynamics in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation A Anandan, P Fu, M Kolk, N Ferrari, A Rashidi, M Copley, J Driscoll, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Impact of Previous Cancer Therapy on Outcome of Patients with Multiple Myeloma or Smoldering Disease F Covut, G Ravi, J Driscoll, M de Lima, E Malek Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| The Prognostic Factors for Early Fatal Outcome in Patients with Multiple Myeloma S Vuyyala, K Chamoun, P Fu, S Cao, MM Gallogly, M de Lima, E Malek Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Meta-Analyses of Clinical Trials Comparing the Progression Free Survival and Adverse Events in Treated Versus Observed Patients with Smoldering and Indolent Multiple Myeloma F Covut, TZ Kewan, A Anandan, F Otegbeye, J Driscoll, M de Lima, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Risk of Progression in Patients with Smoldering Myeloma F Covut, K Chamoun, L Metheny III, KM Boughan, J Driscoll, M de Lima, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young Adults … MJ Wieduwilt, W Stock, AS Advani, SM Luger, RA Larson, MS Tallman, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Filgrastim Administered after Early Assessment Bone Marrow Biopsy during 7+ 3 Induction Therapy for Acute Myeloid Leukemia Reduces Length of Hospital Stay J Wang, KM Boughan, PF Caimi, B Cooper, M de Lima, MM Gallogly, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia L Metheny III, R Sobecks, BK Tomlinson, F Otegbeye, B Cooper, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Stem Cell Transplant Minimizes Insurance Coverage-Driven Outcomes Disparities for Multiple Myeloma Patients G Ravi, K Chamoun, KM Boughan, S Cao, P Fu, M de Lima, E Malek Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| A Phase I Trial of Venetoclax in Combination with BEAM Conditioning Chemotherapy (V-BEAM) with Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma AM Winter, KM Boughan, J Khouri, P Caimi, F Anwer, B Cooper, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Impact of Depth of Pretransplant Clinical Response on Outcomes of Acute Myeloid Leukemia Patients in First Complete Remission (AML-CR1) Who Undergo Allogeneic Hematopoietic … MEM Percival, HL Wang, MJ Zhang, EH Estey, M Litzow, P Kebriaei, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory Lymphomas PF Caimi, J Reese, F Otegbeye, D Schneider, K Bakalarz, KM Boughan, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Lymphoma-Specific Venous Thromboembolism Score (LyV-Score): Use of Lymphoma Subtype to Refine Risk Prediction S Cao, G Dharmavaram, KM Boughan, B Cooper, MM Gallogly, E Malek, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia L Metheny III, W Saber, DJ Weisdorf, M de Lima, NS Callander, M Litzow, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Preclinical Studies and Phase I Trial of Vactosertib in Combination with Pomalidomide in Relapsed Multiple Myeloma: A Corticosteroid-Free Approach By Targeting TGF-β Signaling … E Malek, S Hwang, M de Lima, P Caimi, MM Gallogly, L Metheny III, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Presence of Chip-Mutated Autologous Hematopoietic Cells in Mobilized Peripheral Blood Products Is Associated with Shorter Progression-Free Survival after Autologous Transplants … E Malek, P Martin, PF Caimi, BK Tomlinson, M Caldwell, G Ravi, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| Organ sparing of linac‐based targeted marrow irradiation over total body irradiation GR Warrell, VC Colussi, WL Swanson, PF Caimi, DB Mansur, ... Journal of Applied Clinical Medical Physics, 2019 | | 2019 |
| Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells EO Ojo, AA Sharma, R Liu, S Moreton, MA Checkley-Luttge, K Gupta, ... Scientific reports 9 (1), 1-12, 2019 | | 2019 |
| Impact of Regional Income and Insurance Status on Survival of Multiple Myeloma Patients: Autologous Stem Cell Transplant as an Equalizer K Chamoun, M De Lima, P Fu, PF Caimi, S Cao, S Gerson, KM Boughan, ... Clinical Lymphoma, Myeloma and Leukemia 19 (10), e211-e212, 2019 | | 2019 |
| Risk of Progression Across Age and Race for Patients with Smoldering Multiple Myeloma S Vuyyala, M De Lima, PF Caimi, P Fu, S Cao, L Metheny, B Tomlinson, ... Clinical Lymphoma, Myeloma and Leukemia 19 (10), e325, 2019 | | 2019 |
